Stay updated on NanoFlu Vaccine Safety & Immunogenicity Clinical Trial
Sign up to get notified when there's something new on the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page.

Latest updates to the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 has been added in place of Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new Locations section has been added, featuring North Carolina sites (Raleigh, Rocky Mount, Statesville) and the page revision updated to v3.3.3; the previous North Carolina Locations heading and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.1%

- Check60 days agoChange DetectedDeleted the notice about government funding lapses and NIH/Clinical Center operating status. This removes a temporary site-wide notice and leaves the page without that status information.SummaryDifference0.4%

- Check74 days agoChange DetectedResults data and updated study record dates are now displayed, including the occurrence of Results First Posted 2022-12-21.SummaryDifference0.4%

- Check103 days agoChange DetectedMajor update: new government-status notice and v3.2.0; removed old v3.1.0 reference.”SummaryDifference3%

Stay in the know with updates to NanoFlu Vaccine Safety & Immunogenicity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NanoFlu Vaccine Safety & Immunogenicity Clinical Trial page.